NCT00906048View on ClinicalTrials.gov

LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection

PHASE3TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Infection
Interventions
DRUG

Levofloxacin (HR355) and Rifampicin Therapy

"Film-coated scored tablet measured at 500 mg of levofloxacin and capsule at 300 mg of rifampicin per os once a day~Weight \< 70 kg: 1 tablet of levofloxacin and 2 capsules of rifampicin Weight \> 70 kg: 1 tablet of levofloxacin and 3 capsules of rifampicin"

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Paris

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00906048 - LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection | Biotech Hunter | Biotech Hunter